Insider · CIK 0001704186

Gentile Kimberly

Reports to the SEC for 2 companies · NEW HAVEN, CT

sec.gov

Transactions

Companies

Filings

CIK

0001704186

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-15	BHVNBiohaven Ltd. · Stock Options (Right to buy)A Award	SVP, Clinical Operations	AAward	+1,000 sh	—	—	1,000
2026-02-27	BHVNBiohaven Ltd. · Stock Options (Right to buy)A Award	SVP, Clinical Operations	AAward	+175K sh	—	—	175,000
2026-01-05	BHVNBiohaven Ltd.M Exercise/Conversion	SVP, Clinical Operations	MExercise/Conversion	+3,750 sh	—	—	101,513
2026-01-05	BHVNBiohaven Ltd.F Tax Payment	SVP, Clinical Operations	FTax Payment	−1,956 sh	$9.93	−$19.4K	99,557
2026-01-05	BHVNBiohaven Ltd. · Restricted Share Unit AwardM Exercise/Conversion	SVP, Clinical Operations	MExercise/Conversion	−3,750 sh	—	—	7,500
2025-01-05	BHVNBiohaven Ltd. · Restricted Share Unit AwardA Award	SVP, Clinical Operations	AAward	+15K sh	—	—	15,000
2025-01-05	BHVNBiohaven Ltd. · Stock Options (Right to buy)A Award	SVP, Clinical Operations	AAward	+91K sh	—	—	91,000
2025-01-05	BHVNBiohaven Ltd.F Tax Payment	SVP, Clinical Operations	FTax Payment	−1,956 sh	$38.64	−$75.6K	97,763
2025-01-05	BHVNBiohaven Ltd.M Exercise/Conversion	SVP, Clinical Operations	MExercise/Conversion	+3,750 sh	—	—	99,719
2025-01-05	BHVNBiohaven Ltd. · Restricted Share Unit AwardM Exercise/Conversion	SVP, Clinical Operations	MExercise/Conversion	−3,750 sh	—	—	11,250
2024-01-02	BHVNBiohaven Ltd. · Stock Options (Right to buy)A Award	SVP, Clinical Operations	AAward	+96.3K sh	—	—	96,250
2023-11-02	BHVNBiohaven Ltd. · Stock Options (Right to buy)A Award	SVP, Clinical Operations	AAward	+78.8K sh	—	—	78,750
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardD Disposition to Issuer	SVP, Clinical Operations	DDisposition to Issuer	−3,750 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardD Disposition to Issuer	SVP, Clinical Operations	DDisposition to Issuer	−7,500 sh	—	—	0
2022-10-03	BHVNBiohaven Ltd. · Stock Options (Right to Buy)J Other	SVP, Clinical Operations	JOther	+14K sh	—	—	14,000
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Restricted Share Unit AwardD Disposition to Issuer	SVP, Clinical Operations	DDisposition to Issuer	−13K sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.D Disposition to Issuer	SVP, Clinical Operations	DDisposition to Issuer	−11.7K sh	$148.50	−$1.73M	0
2022-10-03	BHVNBiohaven Ltd.M Exercise/Conversion	SVP, Clinical Operations	MExercise/Conversion	+1,199 sh	$4.13	+$4,951.87	32,149
2022-10-03	BHVNBiohaven Ltd. · Stock Options (Right to Buy)J Other	SVP, Clinical Operations	JOther	+3,000 sh	—	—	3,000
2022-10-03	BHVNBiohaven Ltd.J Other	SVP, Clinical Operations	JOther	+3,750 sh	—	—	16,076
2022-10-03	BHVNBiohaven Ltd.J Other	SVP, Clinical Operations	JOther	+1,875 sh	—	—	17,951
2022-10-03	BHVNBiohaven Ltd.M Exercise/Conversion	SVP, Clinical Operations	MExercise/Conversion	+3,000 sh	$2.52	+$7,560	62,950
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	SVP, Clinical Operations	DDisposition to Issuer	−590 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	SVP, Clinical Operations	DDisposition to Issuer	−41.4K sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	SVP, Clinical Operations	DDisposition to Issuer	−9,000 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	SVP, Clinical Operations	DDisposition to Issuer	−25K sh	—	—	0
2022-10-03	BHVNBiohaven Ltd.M Exercise/Conversion	SVP, Clinical Operations	MExercise/Conversion	+12.5K sh	$0.54	+$6,750	133,461
2022-10-03	BHVNBiohaven Ltd.F Tax Payment	SVP, Clinical Operations	FTax Payment	−37.5K sh	$7.00	−$262K	95,969
2022-10-03	BHVNBiohaven Ltd. · Stock Options (Right to Buy)J Other	SVP, Clinical Operations	JOther	+387 sh	—	—	387
2022-10-03	BHVNBiohaven Ltd. · Stock Options (Right to Buy)J Other	SVP, Clinical Operations	JOther	+12.6K sh	—	—	12,612
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	SVP, Clinical Operations	DDisposition to Issuer	−6,000 sh	—	—	0
2022-10-03	BHVNBiohaven Ltd.M Exercise/Conversion	SVP, Clinical Operations	MExercise/Conversion	+387 sh	$6.37	+$2,465.19	18,338
2022-10-03	BHVNBiohaven Ltd.M Exercise/Conversion	SVP, Clinical Operations	MExercise/Conversion	+31K sh	$1.61	+$49.8K	93,908
2022-10-03	BHVNBiohaven Ltd. · Stock Options (Right to Buy)J Other	SVP, Clinical Operations	JOther	+31K sh	—	—	30,958
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	SVP, Clinical Operations	DDisposition to Issuer	−27.6K sh	—	—	0
2022-10-03	BHVNBiohaven Ltd.M Exercise/Conversion	SVP, Clinical Operations	MExercise/Conversion	+12.6K sh	$6.37	+$80.3K	30,950
2022-10-03	BHVNBiohaven Ltd.M Exercise/Conversion	SVP, Clinical Operations	MExercise/Conversion	+13.8K sh	$4.13	+$57K	45,950
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	SVP, Clinical Operations	DDisposition to Issuer	−2,398 sh	—	—	0
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	SVP, Clinical Operations	DDisposition to Issuer	−28K sh	—	—	0
2022-10-03	BHVNBiohaven Ltd.J Other	SVP, Clinical Operations	JOther	+5,826 sh	—	—	5,826
2022-10-03	BHVNBiohaven Ltd.M Exercise/Conversion	SVP, Clinical Operations	MExercise/Conversion	+295 sh	$1.03	+$303.85	95,745
2022-10-03	BHVNBiohaven Ltd.M Exercise/Conversion	SVP, Clinical Operations	MExercise/Conversion	+20.7K sh	$1.03	+$21.3K	116,461
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	SVP, Clinical Operations	DDisposition to Issuer	−61.9K sh	—	—	0
2022-10-03	BHVNBiohaven Ltd.M Exercise/Conversion	SVP, Clinical Operations	MExercise/Conversion	+14K sh	$2.84	+$39.8K	59,950
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	SVP, Clinical Operations	DDisposition to Issuer	−3,084 sh	—	—	0
2022-10-03	BHVNBiohaven Ltd.J Other	SVP, Clinical Operations	JOther	+6,500 sh	—	—	12,326
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	SVP, Clinical Operations	DDisposition to Issuer	−25.2K sh	—	—	0
2022-10-03	BHVNBiohaven Ltd.M Exercise/Conversion	SVP, Clinical Operations	MExercise/Conversion	+1,542 sh	$1.61	+$2,482.62	95,450
2022-10-03	BHVNBiohaven Ltd. · Stock Options (Right to Buy)J Other	SVP, Clinical Operations	JOther	+1,199 sh	—	—	1,199
2022-10-03	Biohaven Pharmaceutical Holding Co Ltd.Stock Options (Right to Buy)D Disposition to Issuer	SVP, Clinical Operations	DDisposition to Issuer	−775 sh	—	—	0

Recent filings

Accepted (ET)
Sep 174
Gentile Kimberly0001704186-26-000006
SEC(opens sec.gov)
Mar 34
Gentile Kimberly0001704186-26-000004
SEC(opens sec.gov)
Jan 74
Gentile Kimberly0001704186-26-000002
SEC(opens sec.gov)
Jan 74
Gentile Kimberly0001935979-25-000005
SEC(opens sec.gov)
Jan 44
Gentile Kimberly0001562180-24-000285
SEC(opens sec.gov)
Nov 64
Gentile Kimberly0001562180-23-007577
SEC(opens sec.gov)
Oct 54
Gentile Kimberly0001562180-22-007085
SEC(opens sec.gov)

Companies

Address

C/O BIOHAVEN LTD. 215 CHURCH STREET

NEW HAVEN, CT, 06510